Time period given by analyst is Intra Day when Alembic Pharmaceuticals Ltd. price can reach defined target.
Alembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Mid Cap company (having a market cap of Rs 15335.85 Crore) operating in Pharmaceuticals sector.
Alembic Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Export Incentives, Royalty Income and Other Operating Revenue for the year ending 31-Mar-2021.
Financials
For the quarter ended 30-06-2021, the company reported a Consolidated Total Income of Rs 1327.91 Crore, up 3.39 % from last quarter Total Income of Rs 1284.34 Crore and down -1.02 % from last year same quarter Total Income of Rs 1341.64 Crore. Company reported net profit after tax of Rs 148.35 Crore in latest quarter.
Investment Rationale
The stock is on the verge of a breakout from a narrow consolidation phase following its recent corrective move. Further, strong volume build up in the run up before consolidation phase suggests that the breakout should follow. Technical indicator RSI turning upwards from the 40 level is suggesting that a breakout is on the cards.
Promoter/FII Holdings
Promoters held 69.5 per cent stake in the company as of June 30, 2021, while FIIs held 6.4 per cent, DIIs 11.3 per cent and public and others 12.9 per cent.
(Disclaimer: Views and recommendations given in this section are the analysts’ own and do not represent those of ETMarkets.com. Please consult your financial adviser before taking any position in the stock/s mentioned.
